Climb Bio, Inc.

CLYM·NasdaqGM·Healthcare
Compare
9.33−0.42 (−4.31%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market9.32−0.01 (−0.11%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close9.75
Open9.97
Day range9.1910.10
52-week range1.6418.33
Off day high−7.62%
Off 52-week high−49.10%
Volume1.04M
Avg. volume (3M)1.41M
Market cap535.88M
EPS (TTM)-0.8200
Forward P/E-9.30
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-0.01
Shares outstanding57.44M
Short interest24.03% of float
Earnings dateNov 13, 2026 (est.)
Analyst target27.87
Profit margin0.00%

Against its peers

Compare in full ›
CLYM ACRS ABUS CANTA.ST CRVS BHVN
Market cap 535.88M 570.34M 622.30M 475.36M 889.16M 2.30B
P/E (TTM) — — 5.1 2.5 — —
Forward P/E -9.3 -5.1 -24.6 -1.8 -9.9 -8.2
Price/book 2.2 4.1 3.1 1.6 3.9 -23.4
Dividend yield — — — — — —
1-year change +407.81% +65.49% −15.84% −48.13% +30.54% +87.17%
Today −4.31% −1.60% +4.64% −2.09% +7.53% −2.37%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Climb Bio's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Aclaris Therapeutics, Inc.ACRS · Biotechnology 570.34M 3.6800 −1.60%
Arbutus Biopharma CorporationABUS · Biotechnology 622.30M 4.0600 +4.64%
Cantargia AB (publ)CANTA.ST · Biotechnology 475.36M 1.6860 −2.09%
Corvus Pharmaceuticals, Inc.CRVS · Biotechnology 889.16M 10.57 +7.53%
Biohaven Ltd.BHVN · Biotechnology 2.30B 15.24 −2.37%
Zura Bio LimitedZURA · Biotechnology 387.23M 4.0200 +0.75%
Artiva Biotherapeutics, Inc.ARTV · Biotechnology 206.32M 4.2200 +0.48%
ADMA Biologics, Inc.ADMA · Biotechnology 2.35B 10.48 −5.67%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
Olema Pharmaceuticals, Inc.OLMA · San Francisco, CA 659.73M 7.54 +2.59%
Zevra Therapeutics, Inc.ZVRA · Boston, MA 663.32M 11.17 +8.87%
Nuvectis Pharma, Inc.NVCT · Fort Lee, NJ 602.94M 18.47 −4.50%
DBV Technologies S.A.DBVT · Châtillon, France 624.64M 9.94 −1.68%
Geron CorporationGERN · Foster City, CA 693.87M 1.0800 +16.13%
Bicara Therapeutics Inc.BCAX · Boston, MA 588.28M 8.89 −0.78%
MiMedx Group, Inc.MDXG · Marietta, GA 466.96M 3.2000 −1.54%
Iambic Therapeutics, Inc.IAM · San Diego, CA 635.17M 13.40 −0.67%

Also based in Wellesley Hills, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
The TJX Companies, Inc.TJX · Framingham, MA 159.23B 144.76 +5.18%
Vertex Pharmaceuticals IncorporatedVRTX · Boston, MA 139.16B 549.04 +3.44%
Moderna, Inc.MRNA · Cambridge, MAOdds 103.15B 258.38 +13.11%
American Tower CorporationAMT · Boston, MA 90.37B 194.86 +4.04%
Thermo Fisher Scientific Inc.TMO · Waltham, MA 261.64B 706.16 +1.12%
Analog Devices, Inc.ADI · Wilmington, MAOdds 196.85B 406.24 −3.23%
Biogen Inc.BIIB · Cambridge, MA 37.61B 254.46 +2.22%
Akamai Technologies, Inc.AKAM.MX · Cambridge, MA 227.36B 1,582.00 −9.23%

The stocks whose daily moves over the past year went most closely with Climb Bio's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Corvus Pharmaceuticals, Inc.CRVS · Correlation 0.37 889.16M 10.57 +7.53%
CytomX Therapeutics, Inc.CTMX · Correlation 0.34 512.06M 2.3500 +7.80%
Alto Neuroscience, Inc.ANRO · Correlation 0.32 914.34M 23.30 +2.64%

What visitors to Climb Bio's page also look at.

Company Mkt cap Price Today
Artiva Biotherapeutics, Inc.ARTV 206.32M 4.2200 +0.48%
Alto Neuroscience, Inc.ANRO 914.34M 23.30 +2.64%
Oruka Therapeutics, Inc.ORKA 6.71B 101.41 +1.87%
Dianthus Therapeutics, Inc.DNTH 4.80B 85.81 +3.76%
Spyre Therapeutics, Inc.SYRE 9.26B 99.04 −0.23%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All CLYM news ›
markets.businessinsider.com·Positive

Wedbush Remains a Buy on Climb Bio (CLYM)

Wedbush analyst Laura Chico maintained a Buy rating on Climb Bio today and set a price target of $25.00. Chico covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, Vera Therapeutics, and Biogen. According to…

BIIB
Markets Daily·

Climb Bio (NASDAQ:CLYM) Stock Falls 8.7% – Time to Sell?

Posted by Mitch Edgeman on Oct 16th, 2026 Climb Bio, Inc. (NASDAQ:CLYM – Get Free Report)’s share price traded down 8.7% during trading on Friday. The company traded as low as $10.08 and last traded at $9.9650. 318,572 shares traded hands…

BIIBLH

From the 4Search news index, newest first.

In the news

12mentions in 30 days
12with it in the headline
Positivesentiment

Mentioned with

U.S. Food and Drug Administration5Btig Research4Astrazeneca3Bioharvest Sciences Inc3Bioharvest Sciences Inc.3Biolinerx Ltd3Biolinerx Ltd.3Btig Research Bicara Therapeutics3

People in the coverage

Mitch Edgeman5Benzinga4Danessa Lincoln4H.c. Wainwright4DA Davidson3Genmab3

Themes

Healthcare9Finanzen7All News and Stock Ideas5Biotech and Pharma Stock News5Biotechnology5Cancer3HC Wainwright3Pharmaceuticals3

Most coverage from

  1. markets.businessinsider.com7
  2. defenseworld.net1
  3. ir.climbbio.com1
  4. mugglehead.com1
  5. themarketsdaily.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance